Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation

Jun Hyoung Park; Yoon Jung Jang; Yu Jung Choi; Jin Wook Jang; Joo Hyon Kim; Yang Kook Rho; In Ja Kim; Hwa Jung Kim; Moon Jeong Leem; Seung Taek Lee

doi:10.1080/01635581.2013.828090

Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation

Jun Hyoung Park, Yoon Jung Jang, Yu Jung Choi, Jin Wook Jang, Joo Hyon Kim, Yang Kook Rho, In Ja Kim, Hwa Jung Kim, Moon Jeong Leem, Seung Taek Lee

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) play an important role in tissue remodeling during normal physiological situations and pathological implications such as tumor invasion and metastasis. MMP inhibitors were screened from extracts of medicinal herbs by an enzymatic assay using the MMP-14 catalytic domain. Among samples tested, a methanol extract of the root of Dalbergia odorifera T. CHEN (Leguminosae) showed the strongest inhibitory activity. The inhibitory component was purified through fractionation methods and identified as fisetin, abundant in many fruits and vegetables. In addition to inhibition of MMP-14, fisetin inhibits MMP-1, MMP-3, MMP-7, and MMP-9, more efficiently than a naturally occurring MMP inhibitor tetracycline. Fisetin dose-dependently inhibits proliferation of fibrosarcoma HT-1080 cells and human umbilical vascular endothelial cells (HUVECs), MMP-14-mediated activation of proMMP-2 in HT-1080 cells, invasiveness of HT-1080 cells, and in vitro tube formation of HUVECs. Therefore, fisetin could be valuable as a chemopreventive agent against cancer and a lead compound for development of therapeutic MMP inhibitors.

Original language	English
Pages (from-to)	1192-1199
Number of pages	8
Journal	Nutrition and Cancer
Volume	65
Issue number	8
DOIs	https://doi.org/10.1080/01635581.2013.828090
Publication status	Published - 2013

Bibliographical note

Funding Information:
This work was supported by grants from Studies on Ubiq-uitome Functions (2005–2001143 to Seung-Taek Lee), the Mid-Career Researcher Program (2010–0026103 to Seung-Taek Lee), and the National Core Research Center Program (2010–006123 to Hwa-Jung Kim) of the National Research Foundation, Ministry of Education, Science, and Technology, Republic of Korea and by the National R&D Program for Cancer Control (9920180 and 1120110 to Seung-Taek Lee) from Ministry of Health and Welfare, Republic of Korea. Jun Hy-oung Park and Yoon-Jung Jang were predoctoral trainees of the Brain Korea 21 program from Ministry of Education, Science, and Technology, Republic of Korea, and Jun Hyoung Park was a post-doctoral trainee of the 2011 Yonsei University Research Fund. Jun Hyoung Park and Yoon-Jung Jang contributed equally to this article.

All Science Journal Classification (ASJC) codes

Medicine (miscellaneous)
Oncology
Nutrition and Dietetics
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/01635581.2013.828090

Cite this

@article{2b514d56cc0049769435b031c7189df7,

title = "Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation",

abstract = "Matrix metalloproteinases (MMPs) play an important role in tissue remodeling during normal physiological situations and pathological implications such as tumor invasion and metastasis. MMP inhibitors were screened from extracts of medicinal herbs by an enzymatic assay using the MMP-14 catalytic domain. Among samples tested, a methanol extract of the root of Dalbergia odorifera T. CHEN (Leguminosae) showed the strongest inhibitory activity. The inhibitory component was purified through fractionation methods and identified as fisetin, abundant in many fruits and vegetables. In addition to inhibition of MMP-14, fisetin inhibits MMP-1, MMP-3, MMP-7, and MMP-9, more efficiently than a naturally occurring MMP inhibitor tetracycline. Fisetin dose-dependently inhibits proliferation of fibrosarcoma HT-1080 cells and human umbilical vascular endothelial cells (HUVECs), MMP-14-mediated activation of proMMP-2 in HT-1080 cells, invasiveness of HT-1080 cells, and in vitro tube formation of HUVECs. Therefore, fisetin could be valuable as a chemopreventive agent against cancer and a lead compound for development of therapeutic MMP inhibitors.",

author = "Park, {Jun Hyoung} and Jang, {Yoon Jung} and Choi, {Yu Jung} and Jang, {Jin Wook} and Kim, {Joo Hyon} and Rho, {Yang Kook} and Kim, {In Ja} and Kim, {Hwa Jung} and Leem, {Moon Jeong} and Lee, {Seung Taek}",

note = "Funding Information: This work was supported by grants from Studies on Ubiq-uitome Functions (2005–2001143 to Seung-Taek Lee), the Mid-Career Researcher Program (2010–0026103 to Seung-Taek Lee), and the National Core Research Center Program (2010–006123 to Hwa-Jung Kim) of the National Research Foundation, Ministry of Education, Science, and Technology, Republic of Korea and by the National R&D Program for Cancer Control (9920180 and 1120110 to Seung-Taek Lee) from Ministry of Health and Welfare, Republic of Korea. Jun Hy-oung Park and Yoon-Jung Jang were predoctoral trainees of the Brain Korea 21 program from Ministry of Education, Science, and Technology, Republic of Korea, and Jun Hyoung Park was a post-doctoral trainee of the 2011 Yonsei University Research Fund. Jun Hyoung Park and Yoon-Jung Jang contributed equally to this article.",

year = "2013",

doi = "10.1080/01635581.2013.828090",

language = "English",

volume = "65",

pages = "1192--1199",

journal = "Nutrition and Cancer",

issn = "0163-5581",

publisher = "Routledge",

number = "8",

}

TY - JOUR

T1 - Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation

AU - Park, Jun Hyoung

AU - Jang, Yoon Jung

AU - Choi, Yu Jung

AU - Jang, Jin Wook

AU - Kim, Joo Hyon

AU - Rho, Yang Kook

AU - Kim, In Ja

AU - Kim, Hwa Jung

AU - Leem, Moon Jeong

AU - Lee, Seung Taek

N1 - Funding Information: This work was supported by grants from Studies on Ubiq-uitome Functions (2005–2001143 to Seung-Taek Lee), the Mid-Career Researcher Program (2010–0026103 to Seung-Taek Lee), and the National Core Research Center Program (2010–006123 to Hwa-Jung Kim) of the National Research Foundation, Ministry of Education, Science, and Technology, Republic of Korea and by the National R&D Program for Cancer Control (9920180 and 1120110 to Seung-Taek Lee) from Ministry of Health and Welfare, Republic of Korea. Jun Hy-oung Park and Yoon-Jung Jang were predoctoral trainees of the Brain Korea 21 program from Ministry of Education, Science, and Technology, Republic of Korea, and Jun Hyoung Park was a post-doctoral trainee of the 2011 Yonsei University Research Fund. Jun Hyoung Park and Yoon-Jung Jang contributed equally to this article.

PY - 2013

Y1 - 2013

N2 - Matrix metalloproteinases (MMPs) play an important role in tissue remodeling during normal physiological situations and pathological implications such as tumor invasion and metastasis. MMP inhibitors were screened from extracts of medicinal herbs by an enzymatic assay using the MMP-14 catalytic domain. Among samples tested, a methanol extract of the root of Dalbergia odorifera T. CHEN (Leguminosae) showed the strongest inhibitory activity. The inhibitory component was purified through fractionation methods and identified as fisetin, abundant in many fruits and vegetables. In addition to inhibition of MMP-14, fisetin inhibits MMP-1, MMP-3, MMP-7, and MMP-9, more efficiently than a naturally occurring MMP inhibitor tetracycline. Fisetin dose-dependently inhibits proliferation of fibrosarcoma HT-1080 cells and human umbilical vascular endothelial cells (HUVECs), MMP-14-mediated activation of proMMP-2 in HT-1080 cells, invasiveness of HT-1080 cells, and in vitro tube formation of HUVECs. Therefore, fisetin could be valuable as a chemopreventive agent against cancer and a lead compound for development of therapeutic MMP inhibitors.

AB - Matrix metalloproteinases (MMPs) play an important role in tissue remodeling during normal physiological situations and pathological implications such as tumor invasion and metastasis. MMP inhibitors were screened from extracts of medicinal herbs by an enzymatic assay using the MMP-14 catalytic domain. Among samples tested, a methanol extract of the root of Dalbergia odorifera T. CHEN (Leguminosae) showed the strongest inhibitory activity. The inhibitory component was purified through fractionation methods and identified as fisetin, abundant in many fruits and vegetables. In addition to inhibition of MMP-14, fisetin inhibits MMP-1, MMP-3, MMP-7, and MMP-9, more efficiently than a naturally occurring MMP inhibitor tetracycline. Fisetin dose-dependently inhibits proliferation of fibrosarcoma HT-1080 cells and human umbilical vascular endothelial cells (HUVECs), MMP-14-mediated activation of proMMP-2 in HT-1080 cells, invasiveness of HT-1080 cells, and in vitro tube formation of HUVECs. Therefore, fisetin could be valuable as a chemopreventive agent against cancer and a lead compound for development of therapeutic MMP inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84888331607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888331607&partnerID=8YFLogxK

U2 - 10.1080/01635581.2013.828090

DO - 10.1080/01635581.2013.828090

M3 - Article

C2 - 24099040

AN - SCOPUS:84888331607

SN - 0163-5581

VL - 65

SP - 1192

EP - 1199

JO - Nutrition and Cancer

JF - Nutrition and Cancer

IS - 8

ER -

Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this